top of page
  • White LinkedIn Icon
  • White Facebook Icon
Banner Sylvie.png
Banner bleu2.png



  • LinkedIn Social Icône


I began my legal career in business law in Montreal in a leading national law firm. I then went to California for two years and discovered the world of technology start-ups, in which I continue to practice. Upon my return to Montreal, I worked at a national law firm, then with Blue HF. After a solo interlude, I am thrilled to  be working with Blue HF’s great team again. I help my clients with their day-to-day corporate and commercial matters, as well as technology licensing and transfer, financings and merger and acquisitions transactions. I have an enduring interest in biochemistry and molecular biology, which I studied before law, and in ethical questions raised by biotechnology. My other interests include hiking, skiing, reading, and my quest for the drink that goes best with chocolate.



Montreal Bar School, 1996

Compulsory training

Bachelor's degrees in civil and common law, national program (BCL and LL. B.) McGill University, 1995
Great Distinction - Dean's List
Chief Justice Greenshields Award in Criminal Law
John E. Crankshaw Prize in Criminal Law

Master of Science, Molecular Biology and Genetics (M.Sc.)
McGill University, 1993

Bachelor of Science, Biochemistry (B.Sc.) McGill University, 1986

Member of the Quebec Bar 1996
Member of California Bar 2001-2004
Member of the Canadian Bar Association

June 21, 2022

Marc Flood - Sylvie Bordet - Camille Paquette - Émilie Cyr-Lemieux

Potloc, the consumer research company that conducts survey sampling through social networks, secured a $35M Series B financing round. Investissement Québec led the round followed by First Ascent Ventures and initial investors Brightspark Ventures, Desjardins Capital, Cap Horn, EcoFuel, BDC Capital’s Seed Fund along with debt financing provided by CIBC Innovation Banking. Blue HF represented Potloc.

December 22, 2021

Sylvie Bordet - Camille Paquette - Sarah De Rose - Katia Fenelus

Organigram Holdings Inc. acquires an additional $2.5M of secured convertible debentures in Hyasynth Biologicals Inc. (“Hyasynth”), a sustainable biotechnology company and producer of cannabinoid products. Blue HF acted for Hyasynth.

June 23, 2021

Julien Saulgrain - Sylvie Bordet

AlayaCare, a home and community care software company, closed a $225M Series D round led by Generation Investment Management, with participation from Klass Capital, iNovia Capital, Caisse de dépôt et placement du Québec (CDPQ), and Investissement Québec. Blue HF acted for iNovia Capital, CDPQ, and Investissement Québec.

Paramètres des témoins

bottom of page